The PANBIO™ COVID-19 Antigen (Ag) Rapid Test Device is an in vitro diagnostic rapid test device for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19 clinical and or epidemiological criteria. This test is used as an aid in the diagnosis of SARS-CoV-2 infection.
The PCR saliva test is designed to detect whether or not you are currently carrying the SARS-CoV-2 virus that causes COVID-19.
The test is CE marked and results are performed in an IS015189 UK laboratory that is approved to share information with Public Health England (PHE).
With a turnaround time of the test results in 1-3 days, this simple ‘spit test’ is much more user-friendly and non-invasive compared to PCR nasal and throat swab testing for improved sample collection and increased accuracy.
The test is suitable for administration by a registered healthcare professional.
- 100% Sensitivity
- 100% Specificity
Cutting-edge viral RNA qPCR stool test measures levels of SARS-CoV-2, the virus that causes COVID-19.
Screen, monitor, or prevent transmission in patients at risk for COVID-19.
SARS-CoV-2 in stool may be found in up to 53.4% of COVID-19 patients.
The virus may be detected in stool for a period of days to weeks after initial infection.
Intestinal viral infection may play an important role in COVID-19 disease progression and may increase risk for more severe disease.
Detection of SARS-CoV-2 in stool could be used to prevent faecal-oral transmission
We offer both Abbots & Roche ECLIA test
This test is a venous blood draw test, which gets sent off for analysis.
IgG antibody testing can tell whether a person has been previously infected, as the host immune system reacts to the infection by SARS-CoV-2 by producing antibodies from a few days to two weeks after the onset of symptoms. Specific IgG antibodies are produced in the later stages of infection to SARS-CoV-2, and are detectable after RNA is no longer detectable.
The persistence of IgG antibodies allows identification of people who have been infected by SARS-CoV-2.
This test has a minimum sensitivity of 98% and a specificity of 100%, with no cross-reactivity with other viruses.
IgM Antibody Testing can give indication of current infection.
PCR (polymerase chain reaction) samples can come from several different sites in the patient. The simplest is the nasal swab taken from well inside the nose. The back of the throat is another option.
To find evidence of the virus, researchers use PCR to copy and amplify any segments of viral genetic code found in the sample, which makes it easier to detect. This typically involves adding reagents and enzymes, and raising and lowering the temperature of the mixture, known as thermal cycling.
Antigen testing reveals whether someone has a current infection and could therefore pass Covid-19 on to others. PCR is the gold standard in viral diagnostics.